Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-25-075977

Chief Legal Officer sold 9,996 shares at $0.67 ($6,697)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-19 Sale : show line 1 in the form −9,996 $0.67 $6,697 314,296 D
Open-market sales · 9,996 sh · avg $0.67 · $6,697
Loading xslF345X05/ownership.xml…